Transitional cell carcinoma

3 trials 2 recruiting MedDRA PT
3 Registered trials
2 Recruiting
2 Unique sponsors
3 Unique IMPs
3 Commercial trials
Drug classes (ATC)
N Neurology/Psychiatry (ATC N) 2
ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase II/III: 2 Phase I (First in Human): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II/III

2 trials
  • Bicycletx Limited Commercial
    BT8009
    2023-504231-41-00 1 country n=48
    Not authorised
  • Bicycletx Limited Commercial
    ZELENECTIDE PEVEDOTIN
    2023-504231-41-01 18 countries 2024 n=624
    Recruiting

Phase I (First in Human)

1 trial
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Bicycletx Limited Commercial 2 Phase II/III 1
BioNTech SE Commercial 1 Phase I (First in Human) 1
New trials by year
2024
1
2026
1
← All indication landscapes